Dulera
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout Dulera
Dulera is a approved stage product being developed by Merck for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT02045875. Target conditions include Asthma.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02045875 | Approved | Completed |
Competing Products
20 competing products in Asthma